Analysis
Rep. Darrell Issa (R-CA), “Biden’s FTC Is Blocking a Game-Changer for Cancer Patients,” The Hill, June 7, 2023.
Matthew Foldi, “One Government Agency Is Undermining Biden’s Cancer Moonshot,” The Spectator, May 18, 2023.
John Tamny, “Lina Khan Blocks Cancer Cures,” Wall Street Journal, April 27, 2023.
Gerald A. Stein and Marisa Madaras, “Illumina/Grail: FTC Illuminates the Path of Future Vertical Merger Review,” Washington Legal Foundation, April 20, 2023.
Alden Abbott, “When Bad Antitrust Costs Lives: The Illumina/GRAIL Tragedy,” Truth on the Market, April 4, 2023.
Jessica Melugin and Ryan Young, “FTC Antitrust Overreach Threatens Health of American at Risk of Cancer Diagnosis,” Competitive Enterprise Institute, April 3, 2023.
Editorial Board, “Illumina and Antitrust’s Unholy Grail,” Wall Street Journal, September 6, 2022.
Bruce H. Kobayashi and Timothy J. Muris, “A Key FTC Case Goes Down the Regulatory Rabbit Hole,” Barron’s, October 1, 2021.
Bruce H. Kobayashi and Timothy J. Muris, “Screening Out Innovation: Vertical Merger Principles and the FTC’s Misapplication in the Illumina-GRAIL Case,” Competitive Enterprise Institute, August 26, 2021.